C-reactive protein/albumin ratio as a prognostic biomarker in critically ill septic patients: a prospective study Source: Virtual Congress 2020 – Experimental and laboratory studies in intensive care unit medicine Year: 2020
A prospective observational trial examining the value of serum procalcitonin in the diagnosis of pleural infection Source: Annual Congress 2010 - Novel biomarkers and old parameters in approaching pulmonary diseases Year: 2010
Serum ferritin as a prognostic marker of pneumonia: a prospective, single center study Source: International Congress 2018 – Predicting the future: biomarkers of respiratory infection Year: 2018
C-reactive protein level predicts mortality in COPD: a systematic review and meta-analysis Source: Eur Respir Rev 2017; 26: 160070 Year: 2017
C-reactive protein levels and the risk of COPD in a general population: the Rotterdam study Source: Annual Congress 2007 - Mechanisms and new treatments of COPD Year: 2007
D-dimer as a predictor of persistent pulmonary function impairment after COVID-19 pneumonia: a prospective observational study Source: Virtual Congress 2021 – Developments in biomarkers and treatment strategies for chronic lung diseases Year: 2021
C-reactive protein serum levels, genotypes and the risk of COPD. The Rotterdam study Source: Annual Congress 2008 - Genetic risk factors for asthma and COPD Year: 2008
High-sensitive C-reactive protein is associated with reduced lung function in young adults Source: Eur Respir J 2009; 33: 382-388 Year: 2009
Can Neutrophil/lymphocyte Ratio, C-reactive protein (CRP) and Procalcitonin predict the hospitalization time in patients with lower tract respiratory infections ? Source: International Congress 2019 – Pleural infection and complicated pneumonia Year: 2019
Late Breaking Abstract - A composite serum biomarker index for the diagnosis of systemic sclerosis associated interstitial lung disease: a multicentre, observational, cohort study Source: Virtual Congress 2021 – New approaches to diagnostic and prognostic evaluation of interstitial lung diseases of known causes Year: 2021
C-reactive protein as a marker of ventilator-associated pneumonia resolution: a pilot study Source: Eur Respir J 2005; 25: 804-812 Year: 2005
Investigation of protein C activity as a prognostic factor for HCAP; single-center observational study Source: International Congress 2019 – Severe pneumonia: epidemiology, mechanisms and treatment Year: 2019
Calprotectin – A marker of mortality in COPD? Results from a prospective cohort study Source: Annual Congress 2012 - Monitoring of airway diseases: far from the airways Year: 2012
Individual variation in the levels of procalcitonin, neopterin, CRP and MR-proANP during a COPD exacerbation and clinical stable state Source: Annual Congress 2009 - Exacerbations of COPD and bronchiectasis: aetiology and treatment Year: 2009
Does the serum C-reactive protein (CRP) predict adverse outcomes in patients admitted with community acquired pneumonia? Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia Year: 2011
Stability of serum biomarkers and their associations with clinical outcomes in COPD patients and controls: a longitudinal study Source: Annual Congress 2009 - Biomarkers and biology in COPD Year: 2009
Prognosis value of initial C-reactive protein (CRP) assay in patients with community acquired pneumonia Source: Annual Congress 2008 - Community-acquired pneumonia: prognosis, complications and prevention Year: 2008
C-reactive protein (CRP) at admission: is it really usefull in COVID-19 pneumonia? Source: Virtual Congress 2021 – COVID - 19 biomarkers Year: 2021
Changes in pulmonary function and patient-reported outcomes during COVID-19 recovery: a longitudinal, prospective cohort study Source: ERJ Open Res, 7 (3) 00243-2021; 10.1183/23120541.00243-2021 Year: 2021
Development of a new prognosis index (BODS) in patients with COPD:a prospective cohort study Source: International Congress 2018 – What’s hot in rehabilitation in COPD and interstitial lung disease (ILD)? Year: 2018